utilities

Archive | Government and policy

Election countdown: will you help us #campaignfordementia?

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

In every general election, particular issues of the day will always feature heavily in the debate, and as Britain prepares to vote on 8 June, it’s inevitable that Brexit negotiations will dominate the campaign. But our next government will also be able to influence a range of other important issues, including the future of dementia […]

The Dementia Challenge five years on

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

It’s now five years to the day that the first Prime Minister’s Dementia Challenge was launched, setting in motion a comprehensive government plan to tackle dementia. In March 2012, David Cameron detailed an intention to increase research funding, improve dementia care and create a national movement to spread awareness about the condition. So how have […]

NHS England’s budget impact test: what it means for dementia

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

From this month, new measures will come into force that will change the way new treatments are introduced on the NHS in England. You may have seen media reports about the change, and heard that a number of organisations, including Alzheimer’s Research UK, have raised concerns about the measure. So what exactly is happening – […]

MP Daniel Zeichner visits Alzheimer’s Research UK

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

Protecting dementia research in a post-Brexit Britain with Daniel Zeichner MP Even though it has been more than seven months since Britain voted to leave the EU, we are still in a state of uncertainty about exactly what Brexit will look like and we do not yet fully understand the impact this decision will have […]

Over-65s to be given better advice about dementia at NHS Health Checks

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

As the UK’s leading dementia research charity, one of the biggest challenges we face is raising awareness and understanding of dementia. Too often people wrongfully believe dementia is an inevitable part of ageing and that there is nothing they can do to reduce their risk. But that’s not the case, which is why Alzheimer’s Research […]

Keeping up the momentum

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

At Alzheimer’s Research UK we recognise that we aren’t going to defeat dementia on our own. We will need the combined and coordinated effort of a number of different stakeholders, including governments. Therefore, a key strand of activity for the charity is ensuring that dementia research has the support of the UK government. We do […]

Looking to the future

David Mowat MP

I recently attended Alzheimer’s Research UK’s event at the Conservative party conference – “Looking to the future: Innovative approaches in the fight against dementia”. I was impressed with some of the creative ways the charity is raising awareness and highlighting the power of research to defeat dementia. A look at just some of the statistics […]

Read more

New report recommends plan for Government to accelerate access to new medicines at ‘crucial time’ for dementia

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

Today sees the publication of the final report of the Accelerated Access Review, which seeks to accelerate access to all new innovations, including drugs, diagnostics and medical technologies.  The recommendations of this review will be critical in addressing the challenges new dementia treatments are likely to face and will set the scene for access to […]

Drug discovery and the pharmaceutical industry: collaborating for progress

Kirsty MaraisClare van LyndenSusan MitchellEmily CookHelen Davies

Dementia is too big a challenge for one organisation to tackle alone. As the UK’s leading dementia research charity, we’re proud to be funding cutting-edge, innovative science, but we’re also continually working to encourage investment across the board. To develop new treatments for dementia, we need a thriving research sector, and the pharmaceutical industry is a […]